Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q2 2025 Earnings Call Transcript August 1, 2025
Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $12.89, expectations were $8.43.
Operator: Welcome to the Regeneron Pharmaceuticals Second Quarter 2025 Earnings Conference Call. My name is Shannon, and I will be your operator for today’s call. [Operator Instructions]. Please note that this conference call is being recorded. I will now turn the call over to Ryan Crowe,...
